Fração de Ejeção do Ventrículo Esquerdo Aumentada, Diminuída ou Estável ao Longo do Tempo em uma Série de 626 Pacientes com Insuficiência Cardíaca que Receberam Tratamento Médico

Han, Meng-Meng; Zhao, Wen-Shu; Xu, Xiao-Rong; Wang, Xin; Li, Kui-Bao; Dang, Cai-Jing; Zhang, Juan; Liu, Jia-Mei; Chen, Mu-Lei; Yang, Xin-Chun; Xu, Lin; Wang, Hua.
Arq. bras. cardiol ; 117(4): 639-647, Oct. 2021. tab, graf
Artigo Português | LILACS | ID: biblio-1345247

Documentos relacionados

  1. Increased, Decreased, or Stable Left Ventricle Ejection Fraction over Time in a Series of 626 Heart Failure Patients Receiving Medical Treatment.
  2. The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction.
  3. Clinical trajectory of patients with a worsening heart failure event and reduced ventricular ejection fraction.
  4. Identifying racial disparities in the management of heart failure with reduced ejection fraction.
  5. Evaluation of heart failure admission as a surrogate for mortality in randomized clinical trials: A meta-analysis.
  6. Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial.
  7. [Pharmacological treatment of the heart failure according to the ventricular ejection fraction in primary care].
  8. Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea.
  9. Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
  10. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.